$NVAC
NorthView Acquisition Corp

2022 Q4 Form 10-Q Financial Statement

#000121390022071284 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $407.0K $404.4K $340.00
YoY Change 810.33% 118850.0%
Operating Profit -$404.4K
YoY Change
Interest Expense $1.319M $2.211M
YoY Change 118.41%
% of Operating Profit
Other Income/Expense, Net $2.211M
YoY Change
Pretax Income $912.3K $1.807M -$340.00
YoY Change 203.31% -531504.41%
Income Tax $429.7K $42.96K
% Of Pretax Income 47.11% 2.38%
Net Earnings $482.6K $1.764M -$340.00
YoY Change 60.44% -518868.53%
Net Earnings / Revenue
Basic Earnings Per Share $0.07
Diluted Earnings Per Share $0.02 $0.07 -$16.16
COMMON SHARES
Basic Shares Outstanding 24.17M shares 24.17M shares 4.125M shares
Diluted Shares Outstanding 5.194M shares 4.125M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.5K $372.9K
YoY Change -73.9%
Cash & Equivalents $193.5K $372.9K
Short-Term Investments
Other Short-Term Assets $318.2K $332.7K
YoY Change -4.27%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $511.7K $705.5K
YoY Change -53.42%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $194.2M $193.1M $194.0K
YoY Change 1.18% 99429.55%
Total Long-Term Assets $194.2M $193.1M
YoY Change 1.18%
TOTAL ASSETS
Total Short-Term Assets $511.7K $705.5K
Total Long-Term Assets $194.2M $193.1M
Total Assets $194.7M $193.8M $194.0K
YoY Change 0.87% 99793.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.00K
YoY Change
Accrued Expenses $448.5K $320.8K $31.55K
YoY Change 327.53% 916.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $137.8K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $935.8K $400.3K $169.3K
YoY Change 778.55% 136.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $857.8K $969.1K
YoY Change -88.11%
Total Long-Term Liabilities $857.8K $969.1K $0.00
YoY Change -88.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $935.8K $400.3K $169.3K
Total Long-Term Liabilities $857.8K $969.1K $0.00
Total Liabilities $1.830M $1.369M $169.3K
YoY Change -75.0% 708.67%
SHAREHOLDERS EQUITY
Retained Earnings -$620.0K -$374.4K
YoY Change -89.51%
Common Stock $519.00 $519.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$619.5K -$373.9K $24.66K
YoY Change
Total Liabilities & Shareholders Equity $194.7M $193.8M $194.0K
YoY Change 0.87% 99793.23%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $482.6K $1.764M -$340.00
YoY Change 60.44% -518868.53%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$179.4K -$107.9K $0.00
YoY Change -72.92%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$30.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$30.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -179.4K -107.9K 0.000
Cash From Investing Activities -30.00 0.000
Cash From Financing Activities 0.000
Net Change In Cash -179.4K -107.9K 0.000
YoY Change -124.2%
FREE CASH FLOW
Cash From Operating Activities -$179.4K -$107.9K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41177
dei Entity Registrant Name
EntityRegistrantName
NORTHVIEW ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3437271
dei Entity Address Address Line1
EntityAddressAddressLine1
207 West 25th St
dei Entity Address Address Line2
EntityAddressAddressLine2
9th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
494-9022
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
NVAC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24168750 shares
CY2022Q3 us-gaap Cash
Cash
372871 usd
CY2021Q4 us-gaap Cash
Cash
741228 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
332671 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
332396 usd
CY2021Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
25000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
705542 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1098624 usd
CY2022Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
70525 usd
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
308218 usd
CY2022Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
193016803 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
191653961 usd
CY2022Q3 us-gaap Assets
Assets
193792870 usd
CY2021Q4 us-gaap Assets
Assets
193060803 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
320798 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
104898 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
69484 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
10000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1613 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
400282 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
106511 usd
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
969125 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7216022 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1369407 usd
CY2021Q4 us-gaap Liabilities
Liabilities
7322533 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
191647500 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5193750 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
519 usd
CY2022Q3 nvac Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
18975000 shares
CY2021Q4 nvac Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
18975000 shares
CY2022Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.16
CY2021Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.1
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
192797319 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5193750 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5193750 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5193750 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
519 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-374375 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5909749 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-373856 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5909230 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193792870 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193060803 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
404425 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
863546 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
338 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-404425 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-863546 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-338 usd
CY2022Q3 us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
1136826 usd
us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
1371326 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1074374 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6246897 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2211200 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7618223 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1806775 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6754677 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-338 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42962 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69484 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1763813 usd
us-gaap Net Income Loss
NetIncomeLoss
6685193 usd
us-gaap Net Income Loss
NetIncomeLoss
-338 usd
CY2022Q3 nvac Basic Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
BasicWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
18975000 shares
nvac Basic Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
BasicWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
18975000 shares
CY2022Q3 nvac Diluted Net Income Per Share Common Stock Subject To Possible Redemptionin Dollars
DilutedNetIncomePerShareCommonStockSubjectToPossibleRedemptioninDollars
0.07
nvac Diluted Net Income Per Share Common Stock Subject To Possible Redemptionin Dollars
DilutedNetIncomePerShareCommonStockSubjectToPossibleRedemptioninDollars
0.28
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5193750 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4125000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5193750 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4125000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5909230 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1120328 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3709017 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2200213 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-132478 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1212363 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-338 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
24662 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
24662 usd
us-gaap Net Income Loss
NetIncomeLoss
6685193 usd
us-gaap Net Income Loss
NetIncomeLoss
-338 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1371326 usd
CY2022Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-1017341 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1763813 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-373856 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-6246897 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-237418 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
215900 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
338 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
69484 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
8387 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-401841 usd
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
8484 usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
25000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33484 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-368357 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
741228 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
372871 usd
nvac Accretion Of Common Stock To Redemption Value
AccretionOfCommonStockToRedemptionValue
1149819 usd
nvac Deferred Offering Costs Paid Through Issuance Of Founder Shares
DeferredOfferingCostsPaidThroughIssuanceOfFounderShares
25000 usd
nvac Deferred Offering Costs Paid Through Issuance Of Promissory Note
DeferredOfferingCostsPaidThroughIssuanceOfPromissoryNote
137793 usd
nvac Deferred Offering Costs Included In Accrued Offering Costs And Expenses
DeferredOfferingCostsIncludedInAccruedOfferingCostsAndExpenses
31209 usd
CY2021Q4 nvac Purchase Share Of Common Stock Per Share
PurchaseShareOfCommonStockPerShare
11.5
CY2021Q4 nvac Sold Price Per Unit
SoldPricePerUnit
10
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
7959726 usd
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
3450000 usd
CY2022Q3 nvac Shares Cost
SharesCost
3570576 usd
CY2022Q3 nvac Warrants Cost
WarrantsCost
259527 usd
nvac Other Offering Costs
OtherOfferingCosts
679623 usd
CY2022Q3 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Arbitrage Investments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentArbitrageInvestments
0.80 pure
CY2021Q4 nvac Public Offering Amount
PublicOfferingAmount
191647500 usd
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.1
CY2021Q4 nvac Maturity Days
MaturityDays
P185D
nvac Company Obligation Percentage
CompanyObligationPercentage
1 pure
nvac Trust Account Per Public Share
TrustAccountPerPublicShare
10.1
nvac Dissolution Expenses
DissolutionExpenses
100000 usd
nvac Deposit Amount
DepositAmount
1897500 usd
nvac Price Per Share
PricePerShare
0.1
nvac Aggregate Amount
AggregateAmount
3795000 usd
nvac Aggregate Price Per Share
AggregatePricePerShare
0.2
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
5000001 usd
CY2022Q3 nvac Public Per Share
PublicPerShare
10.1
CY2022Q3 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
400000 usd
nvac Unsecured Promissory Note
UnsecuredPromissoryNote
204841 usd
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.01 pure
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.01 pure
us-gaap Debt Instrument Term
DebtInstrumentTerm
P185Y
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
193016803 usd
nvac Gross Unrealized Losses
GrossUnrealizedLosses
-342376 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
192674427 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
191653961 usd
nvac Gross Unrealized Losses
GrossUnrealizedLosses
-12912 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
191641049 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0238 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0103 pure
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q2 nvac Shares Of Common Stock
SharesOfCommonStock
5175000 shares
CY2021Q2 nvac Common Stock Stated Value Per Share
CommonStockStatedValuePerShare
0.0001
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
17404250 shares
nvac Payment Of Stock Issuance Costs
PaymentOfStockIssuanceCosts
7701178 usd
CY2022Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
258548 usd
CY2022Q3 nvac Potential Shares Of Common Stock
PotentialSharesOfCommonStock
17404250 shares
nvac Potential Shares Of Common Stock
PotentialSharesOfCommonStock
17404250 shares
CY2021Q3 nvac Potential Shares Of Common Stock
PotentialSharesOfCommonStock
17404250 shares
nvac Potential Shares Of Common Stock
PotentialSharesOfCommonStock
17404250 shares
nvac Gross Proceeds
GrossProceeds
189750000 usd
nvac Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
-4204248 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-7701178 usd
CY2022Q3 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
13802926 usd
CY2022Q3 nvac Temporary Equity Aggregate Amount Of Redemption Requirement1
TemporaryEquityAggregateAmountOfRedemptionRequirement1
1149819 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
192797319 usd
nvac Gross Proceeds
GrossProceeds
189750000 usd
nvac Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
-4204248 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-7701178 usd
CY2021Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
13802926 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
191647500 usd
CY2021Q4 us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
the Company sold 18,975,000 Units, (which included 2,475,000 Units issued pursuant to the full exercise of the over-allotment option) at a purchase price of $10.00 per Unit. Each unit that the Company is offering has a price of $10.00 and consists of one share of common stock, one right, and one-half of one redeemable warrant. Each right entitles the holder thereof to receive one-tenth (1/10) of one share of common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share, subject to adjustment as described herein.
us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
●in whole and not in part;   ● at a price of $0.01 per warrant;     ● upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”);     ● if, and only if, the last sale price of the common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.  
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
7347500 usd
CY2021Q2 us-gaap Sponsor Fees
SponsorFees
25000 usd
CY2021Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.005
CY2021Q4 nvac Shares Of Common Stock
SharesOfCommonStock
862500 shares
nvac Additional Advanced From Sponsor
AdditionalAdvancedFromSponsor
4841 usd
CY2022Q2 nvac Promissory Note
PromissoryNote
25000 usd
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company effected a 1.1- for-1 stock dividend of its common stock
CY2021Q4 nvac Shares Of Common Stock
SharesOfCommonStock
4743750 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
618750 shares
nvac Common Stock Exceeds Per Share
CommonStockExceedsPerShare
12
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
150000 usd
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
200000 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1500000 usd
nvac Warrants Price Per Share
WarrantsPricePerShare
1
CY2022Q3 nvac Accrued And Charged To Operating Expenses
AccruedAndChargedToOperatingExpenses
15000 usd
nvac Accrued And Charged To Operating Expenses
AccruedAndChargedToOperatingExpenses
48387 usd
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
10000 usd
nvac Business Combination Percentage
BusinessCombinationPercentage
0.0368 pure
nvac Gross Proceeds Amount
GrossProceedsAmount
6986250 usd
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
3570576 usd
nvac Exercisable Per Share
ExercisablePerShare
11.5
CY2022Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Shares Issued
SharesIssued
5175000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
862500 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
450000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5193750 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5193750 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5193750 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5193750 shares
CY2022Q3 nvac Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
18975000 shares
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
969125 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
7216022 usd
nvac Aggregate Value Of Public Warrants
AggregateValueOfPublicWarrants
521813 usd
nvac Aggregate Value Of Public Warrants
AggregateValueOfPublicWarrants
3890177 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0403 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0137 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.03 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.108 pure
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
11.5
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
11.5
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
9.94 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
9.07 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
usd
CY2021Q3 us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
usd
us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
usd
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2021Q3 nvac Basic Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
BasicWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
shares
nvac Basic Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
BasicWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
shares
CY2022Q3 nvac Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
DilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
18975000 shares
nvac Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
DilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
18975000 shares
CY2021Q3 nvac Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
DilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
shares
nvac Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption
DilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption
shares
CY2021Q3 nvac Diluted Net Income Per Share Common Stock Subject To Possible Redemptionin Dollars
DilutedNetIncomePerShareCommonStockSubjectToPossibleRedemptioninDollars
nvac Diluted Net Income Per Share Common Stock Subject To Possible Redemptionin Dollars
DilutedNetIncomePerShareCommonStockSubjectToPossibleRedemptioninDollars
CY2022Q3 nvac Basic Net Income Per Share Common Stock Subject To Possible Redemption
BasicNetIncomePerShareCommonStockSubjectToPossibleRedemption
0.07
nvac Basic Net Income Per Share Common Stock Subject To Possible Redemption
BasicNetIncomePerShareCommonStockSubjectToPossibleRedemption
0.28
CY2021Q3 nvac Basic Net Income Per Share Common Stock Subject To Possible Redemption
BasicNetIncomePerShareCommonStockSubjectToPossibleRedemption
nvac Basic Net Income Per Share Common Stock Subject To Possible Redemption
BasicNetIncomePerShareCommonStockSubjectToPossibleRedemption
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4125000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4125000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5193750 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5193750 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
nvac Accretion Of Common Stock To Redemption Value
AccretionOfCommonStockToRedemptionValue
usd
nvac Deferred Offering Costs Paid Through Issuance Of Founder Shares
DeferredOfferingCostsPaidThroughIssuanceOfFounderShares
usd
nvac Deferred Offering Costs Paid Through Issuance Of Promissory Note
DeferredOfferingCostsPaidThroughIssuanceOfPromissoryNote
usd
nvac Deferred Offering Costs Included In Accrued Offering Costs And Expenses
DeferredOfferingCostsIncludedInAccruedOfferingCostsAndExpenses
usd
nvac Gross Unrealized Gains
GrossUnrealizedGains
usd
nvac Gross Unrealized Gains
GrossUnrealizedGains
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001859807

Files In Submission

Name View Source Status
0001213900-22-071284-index-headers.html Edgar Link pending
0001213900-22-071284-index.html Edgar Link pending
0001213900-22-071284.txt Edgar Link pending
0001213900-22-071284-xbrl.zip Edgar Link pending
f10q0922ex31-1_northviewacq.htm Edgar Link pending
f10q0922ex31-2_northviewacq.htm Edgar Link pending
f10q0922ex32-1_northviewacq.htm Edgar Link pending
f10q0922ex32-2_northviewacq.htm Edgar Link pending
f10q0922_northviewacq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nvac-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
nvac-20220930_cal.xml Edgar Link unprocessable
nvac-20220930_def.xml Edgar Link unprocessable
nvac-20220930_lab.xml Edgar Link unprocessable
nvac-20220930_pre.xml Edgar Link unprocessable
f10q0922_northviewacq_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable